Study
Description |
Protocol |
Turnaround
Time |
Sample
requirements |
In
vivo Testing for Adventitious
Viruses in Embryonated Hen Eggs |
CB100 |
5 -
6 weeks |
14 ml
test article and 14 ml control |
Cell
Growth and Growth Conditions
Optimization |
CB101 |
2 -
4 weeks |
2 X
1 ml (5 x 10(6) cells/ml) |
Cell
Morphology and Growth Characteristics
Studies |
CB102 |
3 -
4 weeks |
2 X
1 ml (10 (7) cells/ml) |
Tumor
Formation in Soft Agar |
CB103 |
3 -
4 weeks |
2 X
1 ml (10 (7) cells/ml) |
Isoenzyme
Electrophoresis for Determination
of Cell Line Origin |
CB104 |
3 -
4 weeks |
2 X
1 ml (10 (7) cells/ml) |
Immunofluorescence
for Identification of Cell line
Origin |
CB105 |
3 -
4 weeks |
2 X
1 ml (10 (7) cells/ml) |
Generation
of Master Cell Banks |
CB106 |
8 -
12 weeks* |
2 X
1 ml (10 (7) cells/ml) |
Cryopreservation
of Cell Lines and Long Term
Storage |
CB107 |
6 -
12 weeks* |
2 X
1 ml (10 (7) cells/ml) |
Master
Virus Seed Stock Preparation |
CB108 |
4 -
14 weeks |
Refer
to Tech Support |
In
vitro Testing for Adventitious
Viruses in Three Cell Lines |
CB109 |
4 weeks |
Refer
to Tech Support |
Virus
Titration |
CB110 |
4 -
5 weeks |
Refer
to Tech Support |
In
vitro Testing for the Presence
of Retro viruses |
CB111 |
4 -
5 weeks |
Refer
to Tech Support |
Sterility
Testing - Membrane Filtration
(GLP) |
CB112 |
3 -
4 weeks |
Refer
to Tech Support |
Sterility
Testing - Membrane Filtration
(Non-GLP) |
CB113 |
3 -
4 weeks |
Refer
to Tech Support |
Sterility
Testing - Direct Inoculation
(GLP) |
CB112a |
3 -
4 weeks |
Refer
to Tech Support |
Sterility
Testing - Direct Inoculation
(Non-GLP) |
CB113a |
3 -
4 weeks |
Refer
to Tech Support |
Mycoplasma
Testing by Multiplex PCR (Non-GLP) |
131 |
1 -
3 days |
1 ml |
Mycoplasma
Screen by Hoechst Staining (Non-GLP) |
CB114 |
1 -
2 weeks |
1 ml |
Mycoplasma
Screen by Hoechst Staining (GLP) |
CB115 |
1 -
2 weeks |
1 ml |
Mycoplasma
Testing by Direct Cultivation
on enriched Mycoplasma Media-GLP |
CB116 |
5 -
6 weeks |
5 ml |
Mycoplasma
Testing by Direct Cultivation
on enriched Mycoplasma Media-
Non-GLP |
CB117 |
5 -
6 weeks |
5 ml |
Mycoplasmal
Testing of Biologicals in Compliance
with 21CFR 610.30 |
CB118 |
5 -
6 weeks |
10 ml
Test Article and 10 ml Control
Fluid |
Mycoplasma
GLP testing (9CFR113.28) for
cultivable Mycoplasmas |
CB119 |
4 -
5 weeks |
10 ml
Test Article and 10 ml Control
Fluid |
Points
to Consider 1993 testing for
Virus Stocks, Monoclonal Antibodies
and Cell Lines (Mycoplasma
Testing) |
CB120 |
5 -
6 weeks |
10 ml
Test Article and 10 ml Control
Fluid |
Bioburden
Testing (GLP) |
CB121 |
3 -
4 weeks |
Refer
to Tech Support |
Bacteriostasis/Fungistasis
(GLP) |
CB122 |
3 -
4 weeks |
Refer
to Tech Support |
Cytotoxicity
in Agar Overlay (L929 Cells) |
CB123 |
4 -
7 days |
3 ml
or 300 mg |
Mycoplasma
Elimination from Contaminated
Cell Lines |
CB124 |
2 -
3.5 weeks |
10 (7)
cells |
Endotoxin
Test (Limulus Amoebocyte Lysate
- LAL) - GLP - Endpoint Assay |
CB125 |
2 -
5 days |
Any |
Endotoxin
Test (Limulus Amoebocyte Lysate
- LAL) - cGMP - Endpoint Assay |
CB126 |
2 -
5 days |
Any |
Residual
Bovine Serum Albumin (BSA) Concentration
by ELISA |
CB127 |
2 -
4 days |
1.0
ml minimum |
Residual
Human Serum Albumin (BSA) Concentration
by ELISA |
CB128 |
2 -
4 days |
1.0
ml minimum |
Endotoxin
Test (Limulus Amoebocyte Lysate
- LAL) - GLP - Kinetic Assay |
CB129 |
2 -
5 days |
Any |
Endotoxin
Test (Limulus Amoebocyte Lysate
- LAL) - cGMP - Kinetic Assay |
CB130 |
2 -
5 days |
Any |